What Makes an Incidental Finding Important Enough to Return to a Participant?

How Important Does an Unexpected Finding Have to Be Before You Return It?

Researchers can encounter many kinds of unexpected information. Some findings suggest an immediate threat to health. Others indicate an elevated future risk. Some might matter only if another test confirms them. Still others are scientifically interesting but offer the participant little useful information.

Clearly, “unexpected” cannot itself be the threshold for disclosure. Nor can researchers reasonably return every anomaly that appears in a dataset.

So where should the line be drawn? The answer usually depends on several characteristics working together, especially whether the finding is reliable, sufficiently significant, and capable of providing meaningful benefit to the participant.

Importance Is a Combination of Validity, Significance, and Potential Benefit

A Finding Can Be Interesting Without Being Important Enough to Return

There is no single universal return threshold

Research ethics has not produced one formula that converts an incidental finding into a returnable finding. Different frameworks use somewhat different terminology and thresholds, particularly across genomics, imaging, population studies, and other research settings.

Still, several considerations recur. Frameworks for return of individual research results and incidental findings commonly examine analytic validity, the seriousness or health significance of the finding, actionability, participant consent or preferences, and the expected balance of benefit and harm.

Rather than asking whether one characteristic is present, it is more useful to ask how these characteristics combine in the particular case.

First threshold: Is the finding analytically valid?

Analytic validity concerns whether the test or analysis accurately identifies the thing it claims to identify. Before asking whether a finding is medically important, researchers need reasonable confidence that the finding itself is real.

This matters because research procedures may be exploratory. An assay may not have been designed for clinical diagnosis. An imaging anomaly may be an artifact. A computational classification may have a meaningful false-positive rate. A genomic result may require confirmation through another process.

Several influential return frameworks make analytic validity a basic requirement for findings that researchers should offer. Some explicitly call for independent confirmation.

Second threshold: Does the finding have established significance?

Validity tells you whether the observation is accurate. It does not tell you what the observation means.

A genetic variant can be measured accurately while its relationship to disease remains uncertain. A physiological value can be accurately recorded without establishing a clinically important condition. Researchers therefore need to consider whether there is sufficient evidence connecting the finding to a meaningful consequence for the participant.

This distinction becomes especially important when dealing with potentially important but highly uncertain findings. Returning uncertain information can transfer scientific uncertainty to the participant without giving them a reliable basis for action.

Third threshold: How serious is the implication?

Seriousness strengthens the case for return. A finding suggesting a substantial risk of a life-threatening or severely disabling condition generally carries more ethical weight than information associated with a minor or inconsequential condition.

Some influential genomic frameworks have used an “established and substantial risk of a serious health condition” as part of the threshold for findings that should generally be offered to consenting participants.

Seriousness, however, should not be confused with certainty. A frightening possible outcome supported by weak evidence does not necessarily create a stronger case for disclosure than a less dramatic but well-established finding.

Fourth threshold: Can the participant do something useful with the information?

Actionability is one of the most influential criteria in return-of-results policies. A finding is clinically actionable when knowing it allows a participant or clinician to take an established action with meaningful potential to prevent a condition, alter its course, change treatment, or undertake appropriate surveillance.

This creates a straightforward ethical argument for return: if reliable information allows someone to avoid serious harm, withholding it becomes harder to justify.

NHGRI notes that many genomic researchers regard medically actionable incidental findings as a minimum category that should be returned following an appropriate informed-consent process, although debate continues about what qualifies as actionable and what additional results should be returned.

Yet actionability should not quietly become the only criterion. The separate question of whether a finding must be clinically actionable before return is more complicated because information can sometimes have reproductive or personal utility even when no treatment exists.

Materiality offers another useful way to frame the threshold

Canada's TCPS 2 uses the concept of a material incidental finding. Its guidance directs researchers to consider analytical validity, potential significance, and actionability when determining materiality. It also emphasizes planning for reasonably foreseeable material incidental findings.

Materiality is useful because it moves the question away from whether a finding is merely unusual. The issue is whether the information is sufficiently consequential to the participant that the research team should have a process for managing it.

Participant preferences remain relevant even when a finding is important

A highly significant finding does not erase participant autonomy. Return frameworks commonly include consent to receive individual findings as part of the decision.

This can become difficult when the information is exceptionally serious or urgent. Researchers may feel a strong protective impulse while the participant has expressed a preference not to receive certain findings. Such conflicts should be anticipated in the protocol rather than left entirely to improvisation.

Whether participants should be allowed to choose which findings they receive and how far a right not to know extends are therefore separate ethical questions.

Potential benefit should be weighed against potential harm

A finding can satisfy several positive criteria and still require consideration of what disclosure may do to the participant. Return can produce anxiety, stigma, unnecessary clinical procedures, financial burdens, misunderstanding, or effects on relatives. Nondisclosure can also cause harm by depriving the participant of an opportunity to prevent or mitigate a serious outcome.

Some influential frameworks therefore distinguish among findings that should be returned because they offer strong net benefit, findings that may be returned because they offer possible net benefit, and findings that generally should not be returned because net benefit is unlikely.

Not every criterion has to be maximized

A tempting but overly rigid approach is to require every finding to be maximally serious, completely certain, immediately actionable, and explicitly requested before it can ever be returned. Existing ethical frameworks are generally more nuanced.

For example, recommendations for biobank research have proposed that findings meeting strong criteria of validity, serious established risk, actionability, and participant consent generally should be offered. The same recommendations allow researchers to consider offering some findings that fall below that threshold when they are analytically valid, have likely health, reproductive, or personal utility, and are expected to provide net benefit from the participant's perspective.

The distinction between “should return” and “may return” is important. Ethical importance exists on a spectrum even when policy ultimately needs operational categories.

Urgency can elevate a finding's importance

Two findings may be equally serious but differ in how quickly action is needed. Information suggesting a preventable danger that requires intervention within days presents a different ethical situation from a risk that can be evaluated routinely over several months.

When delay could materially increase the chance of harm, the research team may need to accelerate expert review, confirmation, or communication according to the study's approved safety procedures. Findings that potentially affect immediate participant health or safety should not be handled as ordinary administrative return-of-results questions.

Importance does not eliminate the need for appropriate communication

The more serious a finding is, the greater the potential harm of communicating it badly. A participant should understand what was found, how certain it is, what the research procedure can and cannot establish, whether confirmation is needed, and what reasonable next step is available.

Researchers should therefore distinguish the decision that a finding is important enough to return from the separate question of who should explain the finding to the participant.

Three Unexpected Findings, Three Different Return Decisions

The exercise shows why “important” cannot mean merely interesting, surprising, or potentially frightening. Importance for return emerges from the quality of the evidence and the consequences of giving or withholding the information.

Common Mistakes When Setting the Return Threshold

Use a Threshold, Not a Hunch

If your study can generate incidental findings, define the characteristics that will trigger further review before those findings appear. Otherwise, particularly dramatic cases can tempt researchers to create a disclosure standard around one participant and then apply a different standard to the next.

The goal is not to reduce ethics to a scoring system. It is to ensure that the same relevant questions are asked consistently and that the threshold for return can be explained to participants, ethics reviewers, and the research team.

Is This Finding Important Enough to Return?

Questions About the Threshold for Returning Incidental Findings

The Strongest Return Decisions Combine Evidence With Consequence

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.